CSM Announces Partnership With IMP to Deliver Clinical Trial Supply Services Globally
TEL AVIV, Israel — CSM has announced its global partnership with IMP, unifying their clinical trial supply services for pharmaceutical and biotechnology companies worldwide. This strategic alliance will allow clinical trial sponsors to streamline the complexities of international supply chain management.
The new partnership is part of CSM’s continued growth and expansion efforts, in delivering best-in-class clinical supplies globally. In addition to CSM and IMP’s current solutions, (packaging and labeling, distribution, storage, sourcing, etc.) this partnership will address global challenges such as regulatory, compliance, QP release, and drug importation for studies.
The partnership was officially announced at IMP’s Clinical Supply Services Launch Event on February 11, 2016 at the David Intercontinental Hotel in Tel-Aviv, Israel. Representing CSM at IMP’s launch event was Gerald Finken, CEO and President, and Bob Albanese, Senior Vice President of Strategic Development. Finken gave an informative presentation for the audience on the topic of Addressing Current Global Clinical Trial Supply Packaging Challenges.